Physical Activity Measured Through Accelerometers & Its Association With

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Clinical Trial Summary

This study will be a cross sectional assessment of physical activity as measured through accelerometers and its association with endothelial function of children with Fontan circulation and healthy age and gender matched controls who are followed at the University of Alberta - Stollery Children's hospital.

See also
Status	Clinical Trial	Phase
Completed	`NCT01239784` - Neurodevelopmental Rehabilitation for Toddlers With Complex Heart Defects	Phase 2
Active, not recruiting	`NCT02110823` - Single Ventricle Reconstruction Extension Study (SVR II) - Pediatric Heart Network
Active, not recruiting	`NCT02455531` - Long-term Outcomes of Children With Hypoplastic Left Heart Syndrome and the Impact of Norwood Shunt Type

NCT number	NCT02938429
Study type	Interventional
Source	University of Alberta
Contact
Status	Completed
Phase	N/A
Start date	October 2016
Completion date	August 31, 2020

Physical Activity Measured Through Accelerometers and Its Association With Endothelial Function in Young Patients With Fontan Physiology

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms